Page last updated: 2024-09-04

ampelopsin and Angiogenesis, Pathologic

ampelopsin has been researched along with Angiogenesis, Pathologic in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, N; Fan, J; Kou, X	1
Han, JM; Jung, HJ; Lim, HN	1
Liu, DY; Luo, GQ; Zeng, S	1

Reviews

1 review(s) available for ampelopsin and Angiogenesis, Pathologic

Article	Year
Potential Molecular Targets of Ampelopsin in Prevention and Treatment of Cancers. Anti-cancer agents in medicinal chemistry, 2017, Volume: 17, Issue:12 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Endoplasmic Reticulum Stress; Flavonoids; Humans; Molecular Structure; Neoplasms; Neovascularization, Pathologic; Reactive Oxygen Species	2017

Other Studies

2 other study(ies) available for ampelopsin and Angiogenesis, Pathologic

Article	Year
Hovenia dulcis Thunb. and its active compound ampelopsin inhibit angiogenesis through suppression of VEGFR2 signaling and HIF-1α expression. Oncology reports, 2017, Volume: 38, Issue:6 Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Chick Embryo; China; Flavonoids; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Plant Extracts; Rhamnaceae; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2	2017
[Inhibitory effects of ampelopsin on angiogenesis]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2006, Volume: 29, Issue:2 Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cattle; Cell Line, Tumor; Cell Proliferation; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Flavonoids; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Plants, Medicinal; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2006

Article

Year

Hovenia dulcis Thunb. and its active compound ampelopsin inhibit angiogenesis through suppression of VEGFR2 signaling and HIF-1α expression.

Oncology reports, 2017, Volume: 38, Issue:6

Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Chick Embryo; China; Flavonoids; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Plant Extracts; Rhamnaceae; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2

2017

[Inhibitory effects of ampelopsin on angiogenesis].

Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2006, Volume: 29, Issue:2

Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cattle; Cell Line, Tumor; Cell Proliferation; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Flavonoids; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Plants, Medicinal; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2006